BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
105.74
-0.59 (-0.55%)
Jun 17, 2025, 10:41 AM - Market open
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
$438,324
Profits / Employee
-$122,258
Market Cap
25.42B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6,772 | 639 | 10.42% |
Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
Dec 31, 2020 | 1,941 | 631 | 48.17% |
Dec 31, 2019 | 1,310 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
BNTX News
- 19 hours ago - 5 Stocks To Ride The German Market Rally - Benzinga
- 4 days ago - BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga
- 5 days ago - BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising. - Barrons
- 5 days ago - BioNTech to acquire CureVac in $1.25 billion all-stock deal - Reuters
- 5 days ago - BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer - GlobeNewsWire
- 6 days ago - RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say - CNBC
- 7 days ago - Vaccine actions and policy positions under US Health Secretary Kennedy - Reuters
- 7 days ago - Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up - Reuters